There are 2789 resources available
276P - Dalpiciclib, a novel CDK4/6 inhibitor, combined with pyrotinib for HER2+ advanced breast cancer: Interim results of a phase II trial
Presenter: Min Yan
Session: ePoster Display
277P - Phase II randomized study of trimebutine maleate and probiotics for abemaciclib-induced diarrhea in patients with HR-positive and HER2-negative advanced breast cancer (MERMAID) WJOG11318B
Presenter: Hiroko Masuda
Session: ePoster Display
278P - Plasmid encoding p62/SQSTM1 administered in combination with CMF chemotherapy improves outcomes in metastatic triple-negative breast cancer patients
Presenter: Sergei Krasny
Session: ePoster Display
279P - Trastuzumab deruxtecan (T-DXd) in patients with HER2-positive metastatic breast cancer (MBC): Updated survival results from a phase II trial (DESTINY-Breast01)
Presenter: Cristina Saura Manich
Session: ePoster Display
318P - Impact of right dose vs on-time chemotherapy on PFS in patients suffering from metastatic breast cancer
Presenter: Anudeep Padakanti
Session: ePoster Display
319P - A propensity score weighted study comparing two versus four-weekly pegylated liposomal doxorubicin regimen in metastatic breast cancer
Presenter: Herve Bischoff
Session: ePoster Display
320P - Prognostic role of meningeal carcinomatosis in breast cancer
Presenter: Renata Meneguetti
Session: ePoster Display
321P - Breast cancer in women younger than 40 years: Increasing proportion of new cases and deaths in Brazil
Presenter: Renata Bonadio
Session: ePoster Display
322P - Intrathecal catheter for chemotherapy in leptomeningeal metastatic breast cancer
Presenter: Lila Autier
Session: ePoster Display
323P - Clinical profile and prognosis of metastatic breast cancer with pseudocirrhosis: A rare and dismal condition
Presenter: Maria Fernanda Simões
Session: ePoster Display